GlassScriptPhysician profile
Stephen K Young
NPI 1659556470
$800.35
in general payments reported to CMS, 2019-2025
11 companies · $191 in 2025
The $191 reported for 2025 was more than what 88% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $169 · 2023: $63.13 · 2024: $210 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acacia Pharma INC | $181.04 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $164.94 | 2022-2025 | Bridion |
| Heron Therapeutics, INC. | $122.15 | 2024 | Aponvie |
| Avanos Medical | $78.75 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $78.31 | 2023-2025 | Dupixent |
| Vertex Pharmaceuticals Incorporated | $52.16 | 2025 | |
| Lilly USA, LLC | $36.22 | 2025 | Omvoh |
| Octapharma USA, INC. | $30.61 | 2025 | Fibryga |
| Pacira Pharmaceuticals Incorporated | $28.90 | 2022-2023 | Exparel, Iovera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.25 | 2021 | |
| Braintree Laboratories, INC. | $12.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.